575 related articles for article (PubMed ID: 22464322)
41. Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?
Germano I; Swiss V; Casaccia P
Neuropharmacology; 2010 May; 58(6):903-10. PubMed ID: 20045420
[TBL] [Abstract][Full Text] [Related]
42. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
43. The Glioma Stem Cell Model in the Era of Single-Cell Genomics.
Suvà ML; Tirosh I
Cancer Cell; 2020 May; 37(5):630-636. PubMed ID: 32396858
[TBL] [Abstract][Full Text] [Related]
44. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
[TBL] [Abstract][Full Text] [Related]
45. Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish.
Jung IH; Leem GL; Jung DE; Kim MH; Kim EY; Kim SH; Park HC; Park SW
Neuro Oncol; 2013 Mar; 15(3):290-304. PubMed ID: 23325864
[TBL] [Abstract][Full Text] [Related]
46. B-cell lymphoma-2 promotes malignant progression in glioma.
Doucette TA; Rao G
Clin Neurosurg; 2011; 58():149-54. PubMed ID: 21916141
[No Abstract] [Full Text] [Related]
47. Dissecting human gliomas by single-cell RNA sequencing.
Tirosh I; Suvà ML
Neuro Oncol; 2018 Jan; 20(1):37-43. PubMed ID: 29016805
[TBL] [Abstract][Full Text] [Related]
48. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.
Lenting K; Khurshed M; Peeters TH; van den Heuvel CNAM; van Lith SAM; de Bitter T; Hendriks W; Span PN; Molenaar RJ; Botman D; Verrijp K; Heerschap A; Ter Laan M; Kusters B; van Ewijk A; Huynen MA; van Noorden CJF; Leenders WPJ
FASEB J; 2019 Jan; 33(1):557-571. PubMed ID: 30001166
[TBL] [Abstract][Full Text] [Related]
49. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling.
Li J; Xu H; Wang Q; Fu P; Huang T; Anas O; Zhao H; Xiong N
Cancer Med; 2019 May; 8(5):2288-2302. PubMed ID: 30848088
[TBL] [Abstract][Full Text] [Related]
50. The dual roles of autophagy in gliomagenesis and clinical therapy strategies based on autophagic regulation mechanisms.
Feng F; Zhang M; Yang C; Heng X; Wu X
Biomed Pharmacother; 2019 Dec; 120():109441. PubMed ID: 31541887
[TBL] [Abstract][Full Text] [Related]
51. Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling.
Hai L; Liu P; Yu S; Yi L; Tao Z; Zhang C; Abeysekera IR; Li T; Tong L; Ma H; Liu B; Xie Y; Zhou X; Lin Y; Zhu M; Zhang K; Ren B; Ming H; Huang Y; Yang X
Cell Physiol Biochem; 2018; 51(6):2925-2937. PubMed ID: 30580328
[TBL] [Abstract][Full Text] [Related]
52. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
53. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M
J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050
[TBL] [Abstract][Full Text] [Related]
54. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
55. The cellular origin for malignant glioma and prospects for clinical advancements.
Zong H; Verhaak RG; Canoll P
Expert Rev Mol Diagn; 2012 May; 12(4):383-94. PubMed ID: 22616703
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of glioma stem cells.
Sampetrean O; Saya H
Brain Tumor Pathol; 2013 Oct; 30(4):209-14. PubMed ID: 23584571
[TBL] [Abstract][Full Text] [Related]
57. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
58. The Updated World Health Organization Glioma Classification: Cellular and Molecular Origins of Adult Infiltrating Gliomas.
Pisapia DJ
Arch Pathol Lab Med; 2017 Dec; 141(12):1633-1645. PubMed ID: 29189064
[TBL] [Abstract][Full Text] [Related]
59. MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway.
Jiang Y; Zhou J; Zhao J; Hou D; Zhang H; Li L; Zou D; Hu J; Zhang Y; Jing Z
EBioMedicine; 2020 Feb; 52():102651. PubMed ID: 32062354
[TBL] [Abstract][Full Text] [Related]
60. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
